Roche buyout was a bad deal for employees - Grunt Employee bei Genentech: Mitarbeiterbewertung

2,0
16. Dez. 2010
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Decent compensation, 4x10 work week, good benefits. Overall very friendly people work here. One of the most casual companies I have ever worked for. Things are changing now, not for the better.

Kontras

Some very horrible mid level management. Schmoozers rise rapidly, jumping job levels every 8 to 16 months. Recent news of layofs has everyone on edge. Old Genentech culture of working for the patient has now become a big pharma regime of cost-cutting and lean times. Conviently disguised by current world-wide economic difficulties. Nice try Roche, your profits aren't really suffering.

Mehr Bewertungen zu Genentech entdecken

5,0
27. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Patient-centric company. great culture & benefits

Kontras

Not always clear how promotions are awarded.

2,0
19. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The work is meaningful and overall the company vision aligns with my goals

Kontras

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle